At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
jejunoileal bypass +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Program on Surgical Control of Hyperlipidemias (POSCH)
In Brief
A Phase 3 clinical trial evaluating jejunoileal bypass and diet, fat-restricted for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To determine whether a profound reduction in serum cholesterol level, induced and maintained by partial ileal bypass, would prevent a second heart attack among men and women who had one myocardial infarction and whose blood cholesterol could not be reduced sufficiently by diet.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
Phase 3CompletedFinished
19721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1973
Study CompletionDec 1997
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartJun 1, 1973
Study CompletionDec 1, 1997
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
jejunoileal bypassprocedure
diet, fat-restrictedbehavioral